-- India's Aurobindo to buy some Actavis businesses in Europe
-- By Aradhana Aravindan
-- Sat Jan 18, 2014 03:20AM EST
-- None



MUMBAI, Jan 18 (Reuters) - Indian drugmaker Aurobindo Pharma Ltd <ARBN.NS> said it agreed to buy Actavis Plc's <ACT.N> commercial operations in seven Western European countries for about 30 million euros ($41 million), in a bid to increase its international footprint.

Aurobindo said the deal would include commercial infrastructure, products and marketing authorizations in the seven countries. The two companies will also enter a long-term commercial and supply deal to support the growth plans of the businesses.